Adage Capital Partners
ARIA

Adage Capital Partners’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Adage Capital Partners’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-562,361
Closed -$4.16M – 751
2016
Q2 		$4.16M Sell
562,361
-4,750,000
-89% -$35.6M 0.01% 606
2016
Q1 		$33.9M Sell
5,312,361
-300,000
-5% -$1.68M 0.09% 254
2015
Q4 		$35.1M Sell
5,612,361
-1,387,639
-20% -$9.11M 0.09% 258
2015
Q3 		$40.9M Buy
7,000,000
+250,000
+4% +$1.93M 0.11% 233
2015
Q2 		$55.8M Sell
6,750,000
-650,000
-9% -$5.75M 0.14% 206
2015
Q1 		$61M Sell
7,400,000
-931,000
-11% -$6.88M 0.15% 194
2014
Q4 		$57.2M Sell
8,331,000
-1,000,000
-11% -$6.25M 0.14% 197
2014
Q3 		$50.4M Buy
9,331,000
+1,362,007
+17% +$7.95M 0.12% 216
2014
Q2 		$50.8M Buy
7,968,993
+1,300,000
+19% +$8.94M 0.13% 209
2014
Q1 		$53.8M Buy
6,668,993
+3,168,993
+91% +$24.7M 0.15% 191
2013
Q4 		$23.9M Buy
3,500,000
+2,429,248
+227% +$13.1M 0.06% 359
2013
Q3 		$19.7M Sell
1,070,752
-1,550,000
-59% -$30.1M 0.06% 384
2013
Q2 		$45.8M Buy
+2,620,752
New +$46.5M 0.14% 192

Other funds holding ARIA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Adage Capital Partners's ARIA Position: Q3 2016 in Review

Adage Capital Partners sold out of Ariad Pharmaceuticals Inc (ARIA) in Q3 2016, closing a stake of 562,361 shares — an estimated $4.16M sold.

Adage Capital Partners first reported a position in ARIA in Q2 2013 and held it in 13 quarters. The position peaked at $61M in Q1 2015. 203 funds tracked by Wall St. Rank hold ARIA as of Q3 2016.

  • Adage Capital Partners reported no remaining Ariad Pharmaceuticals Inc position as of Q3 2016 after selling out during the quarter.
  • Adage Capital Partners sold 562,361 Ariad Pharmaceuticals Inc shares in Q3 2016, an estimated $4.16M.
  • Adage Capital Partners first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 13 quarters.
  • Adage Capital Partners's Ariad Pharmaceuticals Inc position peaked at $61M in Q1 2015.
  • 203 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q3 2016.

Based on Adage Capital Partners's 13F filing for Q3 2016, filed 14 Nov 2016.